FindTrial
Sign In

A 3 month study to observe use of advanced technology to monitor patient progress

A 3 Month Observational Study To Understand The Benefit Of Twins Technology As a Supportive Tool To Enhance Medical Management Of Type II Diabetes Patients Under Ayurvedic Treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/12/022544
Enrollment
5
Registered
2019-12-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Control Intervention1: NIL: NIL

Sponsors

Twins Digtial Services India Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Any patient under Ayurvedic treatment for type 2 diabetes

Exclusion criteria

Exclusion criteria: Type 1 Diabetes, LADA, MODI FCPD [ Fibrocalculous pancreatic diabetes] MODY [Maturity Onset Diabetes Of Young] GDM [Gestational Diabetes Mellitus], Currently pregnant or breastfeeding Known HIV infection Malignancy, SLE Major psychiatric disorder (e.g., schizophrenia, bipolar disorder) Major surgical procedure or significant traumatic injury within 28 days prior to Enrollment Date or anticipation of the need for major surgery during the course of study treatment.

Design outcomes

Primary

MeasureTime frame
Reduced one day average of glucose level as per CGMTimepoint: Reduced one day average of glucose level as per CGM—

Secondary

MeasureTime frame
Average of 5 days glucose value under 140Timepoint: five days—

Countries

India

Contacts

Public ContactDr Anjhana

Twins Digital Services India Pvt Ltd

anjhana@twinsdigital.com9840556883

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026